BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 32558489)

  • 1. Identification of Hub Genes in Gastric Cancer with High Heterogeneity Based on Weighted Gene Co-Expression Network.
    Dong Z; Pei S; Zhao Y; Guo S; Wang Y
    Crit Rev Eukaryot Gene Expr; 2020; 30(2):101-109. PubMed ID: 32558489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intra-tumoral heterogeneity and immune responses predicts prognosis of gastric cancer.
    Feng W; Wang Y; Chen S; Zhu X
    Aging (Albany NY); 2020 Nov; 12(23):24333-24344. PubMed ID: 33259333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and molecular relevance of mutant-allele tumor heterogeneity in breast cancer.
    Ma D; Jiang YZ; Liu XY; Liu YR; Shao ZM
    Breast Cancer Res Treat; 2017 Feb; 162(1):39-48. PubMed ID: 28093659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of hub genes and construction of an mRNA-miRNA-lncRNA network of gastric carcinoma using integrated bioinformatics analysis.
    Wei G; Dong Y; He Z; Qiu H; Wu Y; Chen Y
    PLoS One; 2021; 16(12):e0261728. PubMed ID: 34968391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of sorting nexin 10 weak expression in stomach adenocarcinoma revealed by weighted gene co-expression network analysis.
    Zhang J; Wu Y; Jin HY; Guo S; Dong Z; Zheng ZC; Wang Y; Zhao Y
    World J Gastroenterol; 2018 Nov; 24(43):4906-4919. PubMed ID: 30487700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of 40S ribosomal protein S8 as a novel biomarker for alcohol‑associated hepatocellular carcinoma using weighted gene co‑expression network analysis.
    Bi N; Sun Y; Lei S; Zeng Z; Zhang Y; Sun C; Yu C
    Oncol Rep; 2020 Aug; 44(2):611-627. PubMed ID: 32627011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Weighted gene coexpression network analysis identifies hub genes related to KRAS mutant lung adenocarcinoma.
    Dai D; Shi R; Han S; Jin H; Wang X
    Medicine (Baltimore); 2020 Aug; 99(32):e21478. PubMed ID: 32769881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of novel prognostic biomarkers by integrating multi-omics data in gastric cancer.
    Liu N; Wu Y; Cheng W; Wu Y; Wang L; Zhuang L
    BMC Cancer; 2021 Apr; 21(1):460. PubMed ID: 33902514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of SCN7A as the key gene associated with tumor mutation burden in gastric cancer.
    Li W; Zhou K; Li M; Hu Q; Wei W; Liu L; Zhao Q
    BMC Gastroenterol; 2022 Feb; 22(1):45. PubMed ID: 35123417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive Analysis of lncRNAs Associated with the Pathogenesis and Prognosis of Gastric Cancer.
    Zhang X; Jiang Y; Xie Y; Leng X; Song F
    DNA Cell Biol; 2020 Feb; 39(2):299-309. PubMed ID: 31934786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a tumor microenvironment-related seven-gene signature for predicting prognosis in bladder cancer.
    Wang Z; Tu L; Chen M; Tong S
    BMC Cancer; 2021 Jun; 21(1):692. PubMed ID: 34112144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ACAN, MDFI, and CHST1 as Candidate Genes in Gastric Cancer: A Comprehensive Insilco Analysis.
    Vafaeie F; Nomiri S; Ranjbaran J; Safarpour H
    Asian Pac J Cancer Prev; 2022 Feb; 23(2):683-694. PubMed ID: 35225482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening and Survival Analysis of Hub Genes in Gastric Cancer Based on Bioinformatics.
    Zheng S; Yang L; Dai Y; Jiang L; Wei Y; Wen H; Xu Y
    J Comput Biol; 2019 Nov; 26(11):1316-1325. PubMed ID: 31233344
    [No Abstract]   [Full Text] [Related]  

  • 14. Integrated profiling identifies SLC5A6 and MFAP2 as novel diagnostic and prognostic biomarkers in gastric cancer patients.
    Sun T; Wang D; Ping Y; Sang Y; Dai Y; Wang Y; Liu Z; Duan X; Tao Z; Liu W
    Int J Oncol; 2020 Feb; 56(2):460-469. PubMed ID: 31894266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Weighted correlation network analysis identifies FN1, COL1A1 and SERPINE1 associated with the progression and prognosis of gastric cancer.
    Zhao Q; Xie J; Xie J; Zhao R; Song C; Wang H; Rong J; Yan L; Song Y; Wang F; Xie Y
    Cancer Biomark; 2021; 31(1):59-75. PubMed ID: 33780362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of pivotal genes associated with the prognosis of gastric carcinoma through integrated analysis.
    Ma Z; Xu J; Ru L; Zhu W
    Biosci Rep; 2021 Apr; 41(4):. PubMed ID: 33754626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel biomarkers identified in triple-negative breast cancer through RNA-sequencing.
    Chen YL; Wang K; Xie F; Zhuo ZL; Liu C; Yang Y; Wang S; Zhao XT
    Clin Chim Acta; 2022 Jun; 531():302-308. PubMed ID: 35504321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of early diagnostic biomarkers via WGCNA in gastric cancer.
    Rezaei Z; Ranjbaran J; Safarpour H; Nomiri S; Salmani F; Chamani E; Larki P; Brunetti O; Silvestris N; Tavakoli T
    Biomed Pharmacother; 2022 Jan; 145():112477. PubMed ID: 34864309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Develop a circular RNA-related regulatory network associated with prognosis of gastric cancer.
    Wei S; Teng S; Yao J; Gao W; Zang J; Wang G; Hu Z
    Cancer Med; 2020 Nov; 9(22):8589-8599. PubMed ID: 32902196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Four genes relevant to pathological grade and prognosis in ovarian cancer.
    Pan X; Chen Y; Gao S
    Cancer Biomark; 2020; 29(2):169-178. PubMed ID: 32444534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.